Advertisement
Research Article| Volume 7, ISSUE 3, P531-540, September 1987

Download started.

Ok

Chloramphenicol and Vancomycin

  • Joseph N. Miceli
    Correspondence
    Department of Pharmacology, The Morehouse School of Medicine, 720 Westview Drive, S. W. Atlanta, Georgia 30310
    Affiliations
    Professor, Department of Pharmacology and Medicine, The Morehouse School of Medicine, Atlanta, Georgia
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30728-5
Chloramphenicol and Vancomycin
Previous ArticleMonitoring Aminoglycoside Therapy
Next ArticleFlucytosine (5-fluorocytosine)
      This paper is only available as a PDF. To read, Please Download here.
      These two antibiotics have been important agents in the treatment of serious infections. Chloramphenicol use is decreasing owing to the potentially fatal toxicities associated with its use. Vancomycin use, on the other hand, is increasing owing to the emergence of methicillin-resistant staphylococci. It is important to routinely monitor serum concentrations of these drugs. An overview of the pharmacology and methods of analysis for each drug is presented in this review.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Akronheim G.A.
        • Reich B.
        • Marks M.I.
        Penicillin insensitive pneumococci.
        Am J Dis Child. 1979; 133: 187-191
        • Ambrose P.J.
        Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.
        Clin Pharmacokinet. 1984; 9: 222-238
        • Aravind M.K.
        • Miceli J.N.
        • Done A.K.
        • Kauffman R.E.
        Determination of chloramphenicol-glucuronide in urine by high performance liquid chromatography.
        J Chromatogr. 1982; 232: 461-464
        • Aravind M.K.
        • Miceli J.N.
        • Kauffman R.E.
        • et al.
        Simultaneous measurement of chloramphenicol and chloramphenicol succinate by high performance liquid chromatography.
        J Chromatogr. 1980; 221: 176-181
        • Baumelou E.
        • Najean Y.
        Why still prescribe chloramphenicol in 1983?.
        Blut. 1983; 47: 317-320
        • Boeckx R.L.
        • Brett E.M.
        A bioluminescence micromethod for measuring chloramphenicol in serum.
        Clin Chem. 1981; 27: 819-822
        • Brown W.J.
        • Waatti P.E.
        Susceptibility testing of clinically isolated anaerobic bacteria by an agar dilution technique.
        Antimicrob Agents Chemother. 1980; 17: 629-635
        • Burns L.E.
        • Hodgman J.E.
        • Cass A.B.
        Fatal circulatory collapse in premature infants receiving chloramphenicol.
        N Engl J Med. 1959; 261: 1318-1321
        • Campbell G.S.
        • Magean R.P.
        • Schoob B.
        • Johnston R.W.
        Detection and quantitation of chloramphenicol by competitive enzyme linked immunoassay.
        Antimicrob Agents Chemother. 1984; 25: 205-211
        • Crechiolo J.
        • Hill R.E.
        Determination of serum chloramphenicol by high performance liquid chromatography.
        J Chromatogr. 1979; 162: 480-484
        • Crossely K.
        • Loesch D.
        • Landesman B.
        • et al.
        An outbreak of infection caused by a strain of Staphylococcus aureus resistant to methicillin and aminoglycosides. I. Clinical studies.
        J Infect Dis. 1979; 139: 273-279
        • Crossley K.B.
        • Rostchafer M.M.
        • Chern K.E.
        • et al.
        Comparison of a radioimmunoassay and a microbiological assay for measurement of serum vancomycin concentrations.
        Antimicrob Agents Chemother. 1981; 17: 654-657
        • Daigneault R.
        • Guitard M.
        An enzymatic assay for chloramphenicol with partially purified chloramphenicol acetyltransferase.
        J Infect Dis. 1976; 133: 515-522
        • Dong J.
        • DeRoeck A.
        Hydrolysis and absorption of chloramphenicol palmitate.
        J Pharm Belg. 1975; 30: 475-483
        • Ehrlich J.
        • Bartz Q.R.
        • Smith R.M.
        • et al.
        Chloromycetin, a new antibiotic from a soil actinomycete.
        Science. 1947; 106: 417-419
        • Farber B.F.
        • Moellering Jr, R.C.
        Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981.
        Antimicrob Agents Chemother. 1983; 23: 138-141
        • Farber B.B.
        Vancomycin: Renewed interest in an old drug.
        Eur J Clin Microbiol. 1984; 3: 1-3
        • Fong K.I.
        • Ho D.H.W.
        • Bogend L.
        • et al.
        Sensitive radioimmunoassay for vancomycin.
        Antimicrob Agents Chemother. 1981; 19: 139-143
        • Gal J.
        • Marcell P.D.
        • Tarascio C.M.
        High performance liquid chromatographic microassay for chloramphenicol in human blood plasma and cerebrospinal fluid.
        J Chromatogr. 1980; 181: 123-126
        • Geraci J.E.
        • Hermann P.E.
        Vancomycin.
        Mayo Clin Proc. 1983; 58: 88-91
        • Glazko A.J.
        • Carnes A.K.
        • Kazenko A.
        • et al.
        Succinic acid esters of chloramphenicol.
        Antibiotics Ann. 1957-1958; 5: 792-802
        • Glazko A.J.
        • Edgerton W.H.
        • Dill W.A.
        • Lenz W.R.
        Chloromycetin palmitate: A synthetic ester of chloromycetin.
        Antibiot Chemother. 1952; 2: 234-242
        • Glazko A.J.
        • Wolf L.M.
        • Dill W.A.
        Chemical studies on chloramphenicol. I. Colorimetric methods for determination of chloramphenicol and related nitro compounds.
        Arch Biochem. 1949; 23: 411-418
        • Glew R.H.
        • Pavuk R.A.
        • Shuster A.
        • Alfred H.J.
        Vancomycin pharmacokinetics in patients undergoing chronic intermittent peritoneal dialysis.
        Int J Clin Pharmacol Ther Toxicol. 1982; 20: 559-563
        • Griffith R.S.
        Vancomycin use—a historical review.
        J Antimicrob Chemother. 1984; 14: 1-5
        • Gunn B.A.
        • Woodall J.B.
        • Jones J.F.
        Ampicillin-resistant Haemophilus influenzae.
        Lancet. 1974; 2: 845-846
        • Hoagland R.J.
        • Sherwin J.E.
        • Phillips Jr, J.M.
        Vancomycin—a rapid HPLC assay for a potent antibiotic.
        J Anal Toxicol. 1984; 8: 75-77
        • Jehl F.
        • Gallion C.
        • Thierry R.C.
        • Monteil H.
        Determination of vancomycin in human serum by high pressure liquid chromatography.
        Antimicrob Agents Chemother. 1985; 27: 503-507
        • Karchmer A.W.
        • Archer G.L.
        • Diamukes W.
        Staphylococcus epidermidis prosthetic value endocarditis: Microbiologic and clinical observations as guides to therapy.
        Ann Intern Med. 1983; 98: 138-141
        • Kauffman R.E.
        The role of chloramphenicol in pediatric therapy.
        in: MacLeod S.M. Okey A.B. Spielberg S.P. Developmental Pharmacology. Alan R Liss, New York1983: 315-327
        • Kauffman R.E.
        • Miceli J.N.
        • Strebei L.
        • et al.
        Pharmacokinetics of chloramphenicol and chloramphenicol succinate in infants and children.
        J Pediatr. 1981; 98: 315-320
        • Klimik J.
        • Marsik F.
        • Bartlett R.C.
        • et al.
        Clinical epidemiologic and bacteriologic Staphylococcus aureus in a large community hospital.
        Am J Med. 1976; 61: 340-345
        • Krogstad D.J.
        • Moellering Jr, R.C.
        • Greenblatt D.J.
        Single-dose kinetics of intravenous vancomycin.
        J Clin Pharmacol. 1980; 20: 197-201
        • Kurers A.
        Vancomycin.
        J Antimicrob Chemother. 1984; 14: 564-567
        • Lietman P.S.
        • White T.J.
        • Shaw W.V.
        Chloramphenicol: An enzymological microassay.
        Antimicrob Agents Chemother. 1976; 10: 347-353
        • Matzke G.R.
        • Zhanel G.G.
        • Guay D.R.P.
        Clinical pharmacokinetics of vancomycin.
        Clin Pharmacokinetics. 1986; 11: 257-282
        • McHenry M.C.
        • Gavan T.L.
        Vancomycin.
        Pediatr Clin North Am. 1983; 30: 31-47
        • Miceli J.N.
        • Kauffman R.E.
        HPLC in non-routine drug monitoring.
        Lab Management. 1984; 22: 39-48
        • Moellering Jr, R.C.
        • Krogstad D.J.
        • Greenblatt D.J.
        Vancomycin therapy in patients with impaired renal function: A nomogram for dosage.
        Ann Intern Med. 1981; 94: 343-346
        • Moellering Jr, R.C.
        • Krogstad D.J.
        • Greenblatt D.J.
        Pharmacokinetics of vancomycin in normal subjects and in patients with reduced renal function.
        Rev Infect Dis. 1981; 3: S230-S235
        • Moellering Jr, R.C.
        Pharmacokinetics of vancomycin.
        J Antimicrob Chemother. 1984; 14: 43-52
        • Oseekey K.B.
        • Rowse K.L.
        • Kostenbauder H.B.
        High performance liquid chromatographic determination of chloramphenicol and its monosuccinate ester in plasma.
        J Chromatogr. 1980; 182: 459-464
        • Pfaller M.A.
        • Krogstad D.J.
        • Granick G.G.
        • Murray P.R.
        Laboratory evaluation of five assay methods for vancomycin: Bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay and fluorescence immunoassay.
        J Clin Microbiol. 1984; 20: 311-316
        • Pickering L.K.
        • Hoecker J.L.
        • Kramer W.G.
        • et al.
        Assays for chloramphenicol compared: Radioenzymatic, gas chromatographic with electron capture and gas chromatographic mass spectrometric.
        Clin Chem. 1979; 25: 300-305
        • Pohlod D.J.
        • Saravolatz L.D.
        • Somerville M.M.
        Comparison of fluorescence polarization immunoassay and bioassay of vancomycin.
        Ther Drug Monit. 1983; 5: 341-345
        • Resnick G.L.
        • Corbin D.
        • Sandberg D.H.
        Determination of serum chloramphenicol utilizing gas liquid chromatography and electron capture spectrometry.
        Anal Chem. 1986; 38: 582-585
        • Rich M.L.
        • Ritterhoff R.J.
        • Hoffmann R.J.
        A fatal case of aplastic anemia following chloramphenicol (chloromycetin) therapy.
        Ann Intern Med. 1950; 33: 1459-1467
        • Ristuccia P.A.
        • Ristuccia A.M.
        • Bidanset J.H.
        • Cunka B.A.
        Comparison of bioassay, high-performance liquid chromatography, and fluorescence polarization immunoassay for quantitative determination of vancomycin in serum.
        Ther Drug Monit. 1984; 6: 238-242
        • Rotschafer J.C.
        • Crossley K.
        • Zaske D.E.
        • et al.
        Pharmacokinetics of vancomycin: Observations in 28 patients and dosage recommendations.
        Antimicrob Agents Chemother. 1982; 22: 391-394
        • Sample R.H.B.
        • Glick M.R.
        • Kleiman M.B.
        • et al.
        High pressure liquid chromatographic assay of chloramphenicol in biological fluids.
        Antimicrob Agents Chemother. 1979; 15: 491-493
        • Saidi P.
        • Wallerstein R.P.
        • Aggeler P.M.
        Effect of chloramphenicol on erythropoiesis.
        J Lab Clin Med. 1961; 57: 247-256
        • Schmidt F.H.
        • Vomel W.
        Uber die Spaltunz von Chloramphenicolsuccinate durch tierische und menschliche Gwewbe.
        Klin Wochenschr. 1965; 43: 535-539
        • Schwenzer K.S.
        • Wang C.H.J.
        • Anhalt J.P.
        Automated fluorescence polarization immunoassay for monitoring vancomycin.
        Ther Drug Monit. 1983; 5: 341-345
        • Shalit I.
        • Marks M.I.
        Chloramphenicol in the 1980s.
        Drugs. 1984; 28: 281-291
        • Smith D.G.
        • Londers C.G.
        • Forgacs J.
        A cylinder paste assay for chloromycetin in body fluids and tissue extracts.
        J Lab Clin Med. 1950; 36: 154-157
        • Smith A.L.
        • Smith D.H.
        Improved enzymatic assay of chloramphenicol.
        Clin Chem. 1978; 24: 1452-1457
        • Sutherland J.M.
        Fatal cardiovascular collapse in infants receiving large amounts of chloramphenicol.
        Am J Dis Child. 1959; 97: 761-767
        • Thies R.L.
        • Fischer L.J.
        High performance liquid chromatographic assay for chloramphenicol in biological fluids.
        Clin Chem. 1978; 24: 778-781
        • Uhl J.R.
        • Anhalt J.P.
        High performance liquid chromatographic assay of vancomycin in serum.
        Ther Drug Monit. 1979; 1: 75-83
        • Velagapudi R.
        • Smith R.V.
        • Ludden T.M.
        • Sagraves R.
        Simultaneous determination of chloramphenicol and chloramphenicol succinate in plasma using high performance liquid chromatography.
        J Chromatogr. 1982; 228: 423-428
        • Walker C.A.
        • Kopp B.
        Sensitive bioassay for vancomycin.
        Antimicrob Agents Chemother. 1978; 13: 30-33
        • Yunis A.A.
        Chloramphenicol induced bone marrow suppression.
        Semin Hematol. 1973; 10: 225-234

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30728-5

      Copyright

      © 1987 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX